2 results
Approved WMOCompleted
Primary: Effectivity. Secundary: Effectivity (questionnaires, progression, surgery), safety and tolerability.
Approved WMOCompleted
Is to evaluate long-term safety of oral levosimendan in amyotrophic lateral sclerosis (ALS) patients.